Annual EBIT
-$118.38 M
-$6.29 M-5.61%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual earnings before interest & taxes is currently -$118.38 million, with the most recent change of -$6.29 million (-5.61%) on 31 December 2023. During the last 3 years, it has fallen by -$67.87 million (-134.36%). TNXP annual EBIT is now -560942.65% below its all-time high of -$21.10 thousand, reached on 31 December 2008.TNXP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$13.89 M
+$4.47 M+24.36%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly earnings before interest & taxes is currently -$13.89 million, with the most recent change of +$4.47 million (+24.36%) on 30 September 2024. Over the past year, it has increased by +$14.26 million (+50.67%). TNXP quarterly EBIT is now -578483.33% below its all-time high of -$2400.00, reached on 30 June 2010.TNXP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$80.92 M
+$14.26 M+14.98%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding TTM earnings before interest & taxes is currently -$80.92 million, with the most recent change of +$14.26 million (+14.98%) on 30 September 2024. Over the past year, it has increased by +$42.85 million (+34.62%). TNXP TTM EBIT is now -899066.67% below its all-time high of -$9000.00, reached on 31 March 2008.TNXP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.6% | +50.7% | +34.6% |
| 3 y3 years | -134.4% | +25.1% | -1.3% |
| 5 y5 years | -349.7% | -76.0% | -191.7% |
TNXP EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -134.4% | at low | at high | +59.0% | -1.3% | +35.4% |
| 5 y | 5 years | -349.7% | at low | -90.3% | +59.0% | -191.7% | +35.4% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +59.0% | <-9999.0% | +35.4% |
Tonix Pharmaceuticals Holding EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$13.89 M(-24.4%) | -$80.92 M(-15.0%) |
| June 2024 | - | -$18.36 M(-14.0%) | -$95.19 M(-10.1%) |
| Mar 2024 | - | -$21.35 M(-21.9%) | -$105.83 M(-10.6%) |
| Dec 2023 | -$118.38 M(+5.6%) | -$27.33 M(-2.9%) | -$118.38 M(-4.4%) |
| Sept 2023 | - | -$28.15 M(-2.9%) | -$123.78 M(-1.2%) |
| June 2023 | - | -$29.00 M(-14.5%) | -$125.22 M(+4.7%) |
| Mar 2023 | - | -$33.90 M(+3.6%) | -$119.56 M(+6.7%) |
| Dec 2022 | -$112.09 M(+21.4%) | -$32.73 M(+10.6%) | -$112.09 M(+3.0%) |
| Sept 2022 | - | -$29.59 M(+26.8%) | -$108.84 M(+11.3%) |
| June 2022 | - | -$23.34 M(-11.7%) | -$97.79 M(-0.2%) |
| Mar 2022 | - | -$26.44 M(-10.3%) | -$98.01 M(+6.2%) |
| Dec 2021 | -$92.31 M(+82.8%) | -$29.48 M(+59.0%) | -$92.31 M(+15.6%) |
| Sept 2021 | - | -$18.54 M(-21.3%) | -$79.86 M(+8.9%) |
| June 2021 | - | -$23.56 M(+13.6%) | -$73.32 M(+14.7%) |
| Mar 2021 | - | -$20.74 M(+21.8%) | -$63.95 M(+26.6%) |
| Dec 2020 | -$50.51 M(+75.2%) | -$17.02 M(+41.9%) | -$50.51 M(+19.6%) |
| Sept 2020 | - | -$12.00 M(-15.5%) | -$42.22 M(+10.8%) |
| June 2020 | - | -$14.19 M(+94.5%) | -$38.11 M(+27.8%) |
| Mar 2020 | - | -$7.30 M(-16.5%) | -$29.83 M(+3.5%) |
| Dec 2019 | -$28.83 M(+9.5%) | -$8.73 M(+10.7%) | -$28.83 M(+3.9%) |
| Sept 2019 | - | -$7.89 M(+33.6%) | -$27.74 M(+9.3%) |
| June 2019 | - | -$5.91 M(-6.2%) | -$25.39 M(-0.9%) |
| Mar 2019 | - | -$6.30 M(-17.7%) | -$25.63 M(-2.6%) |
| Dec 2018 | -$26.32 M(+23.6%) | -$7.65 M(+38.1%) | -$26.32 M(+8.7%) |
| Sept 2018 | - | -$5.54 M(-9.8%) | -$24.21 M(-1.2%) |
| June 2018 | - | -$6.14 M(-12.1%) | -$24.51 M(+5.7%) |
| Mar 2018 | - | -$6.99 M(+26.1%) | -$23.19 M(+8.9%) |
| Dec 2017 | -$21.29 M(-45.4%) | -$5.54 M(-5.0%) | -$21.29 M(-8.5%) |
| Sept 2017 | - | -$5.83 M(+21.0%) | -$23.26 M(-7.1%) |
| June 2017 | - | -$4.82 M(-5.3%) | -$25.03 M(-16.7%) |
| Mar 2017 | - | -$5.09 M(-32.2%) | -$30.05 M(-22.9%) |
| Dec 2016 | -$38.97 M | -$7.51 M(-1.3%) | -$38.97 M(-13.1%) |
| Sept 2016 | - | -$7.61 M(-22.6%) | -$44.86 M(-11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | -$9.84 M(-29.8%) | -$50.53 M(-3.7%) |
| Mar 2016 | - | -$14.01 M(+4.6%) | -$52.48 M(+9.0%) |
| Dec 2015 | -$48.16 M(+74.1%) | -$13.40 M(+0.9%) | -$48.16 M(+10.0%) |
| Sept 2015 | - | -$13.28 M(+12.7%) | -$43.76 M(+15.4%) |
| June 2015 | - | -$11.78 M(+21.5%) | -$37.92 M(+17.8%) |
| Mar 2015 | - | -$9.70 M(+7.7%) | -$32.18 M(+16.4%) |
| Dec 2014 | -$27.66 M(+154.0%) | -$9.00 M(+21.1%) | -$27.66 M(+23.7%) |
| Sept 2014 | - | -$7.43 M(+22.9%) | -$22.36 M(+24.1%) |
| June 2014 | - | -$6.05 M(+17.0%) | -$18.02 M(+28.2%) |
| Mar 2014 | - | -$5.17 M(+39.4%) | -$14.06 M(+29.1%) |
| Dec 2013 | -$10.89 M(+38.9%) | -$3.71 M(+20.0%) | -$10.89 M(+19.7%) |
| Sept 2013 | - | -$3.09 M(+48.2%) | -$9.10 M(+17.5%) |
| June 2013 | - | -$2.09 M(+4.2%) | -$7.74 M(+3.1%) |
| Mar 2013 | - | -$2.00 M(+4.4%) | -$7.50 M(+13.4%) |
| Dec 2012 | -$7.84 M(+132.0%) | -$1.92 M(+10.5%) | -$6.61 M(+6.8%) |
| Sept 2012 | - | -$1.73 M(-6.3%) | -$6.19 M(+13.2%) |
| June 2012 | - | -$1.85 M(+66.3%) | -$5.47 M(+37.6%) |
| Mar 2012 | - | -$1.11 M(-25.5%) | -$3.98 M(+17.7%) |
| Dec 2011 | -$3.38 M(+75.2%) | -$1.49 M(+47.3%) | -$3.38 M(-11.1%) |
| Sept 2011 | - | -$1.01 M(+185.1%) | -$3.80 M(+36.2%) |
| June 2011 | - | -$355.80 K(-30.7%) | -$2.79 M(+14.5%) |
| Mar 2011 | - | -$513.70 K(-73.2%) | -$2.44 M(+26.3%) |
| Dec 2010 | -$1.93 M(+6141.7%) | -$1.92 M(>+9900.0%) | -$1.93 M(>+9900.0%) |
| Sept 2010 | - | -$3700.00(+54.2%) | -$15.40 K(+7.7%) |
| June 2010 | - | -$2400.00(-58.6%) | -$14.30 K(-44.6%) |
| Mar 2010 | - | -$5800.00(+65.7%) | -$25.80 K(-16.5%) |
| Dec 2009 | -$30.90 K(+46.4%) | -$3500.00(+34.6%) | -$30.90 K(+1.3%) |
| Sept 2009 | - | -$2600.00(-81.3%) | -$30.50 K(-3.5%) |
| June 2009 | - | -$13.90 K(+27.5%) | -$31.60 K(+37.4%) |
| Mar 2009 | - | -$10.90 K(+251.6%) | -$23.00 K(+9.0%) |
| Dec 2008 | -$21.10 K | -$3100.00(-16.2%) | -$21.10 K(+17.2%) |
| Sept 2008 | - | -$3700.00(-30.2%) | -$18.00 K(+25.9%) |
| June 2008 | - | -$5300.00(-41.1%) | -$14.30 K(+58.9%) |
| Mar 2008 | - | -$9000.00 | -$9000.00 |
FAQ
- What is Tonix Pharmaceuticals Holding annual earnings before interest & taxes?
- What is the all time high annual EBIT for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual EBIT year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly EBIT year-on-year change?
- What is Tonix Pharmaceuticals Holding TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding TTM EBIT year-on-year change?
What is Tonix Pharmaceuticals Holding annual earnings before interest & taxes?
The current annual EBIT of TNXP is -$118.38 M
What is the all time high annual EBIT for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual earnings before interest & taxes is -$21.10 K
What is Tonix Pharmaceuticals Holding annual EBIT year-on-year change?
Over the past year, TNXP annual earnings before interest & taxes has changed by -$6.29 M (-5.61%)
What is Tonix Pharmaceuticals Holding quarterly earnings before interest & taxes?
The current quarterly EBIT of TNXP is -$13.89 M
What is the all time high quarterly EBIT for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly earnings before interest & taxes is -$2400.00
What is Tonix Pharmaceuticals Holding quarterly EBIT year-on-year change?
Over the past year, TNXP quarterly earnings before interest & taxes has changed by +$14.26 M (+50.67%)
What is Tonix Pharmaceuticals Holding TTM earnings before interest & taxes?
The current TTM EBIT of TNXP is -$80.92 M
What is the all time high TTM EBIT for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high TTM earnings before interest & taxes is -$9000.00
What is Tonix Pharmaceuticals Holding TTM EBIT year-on-year change?
Over the past year, TNXP TTM earnings before interest & taxes has changed by +$42.85 M (+34.62%)